ROGDI是一個功能未知的基因，位於人類染色體16p13.3上，遺傳編碼區有864 bp，轉譯出287個胺基酸。前人的研究指出過量表現ROGDI會促使數種細胞株增生。CDK2是一個會分別與cyclin E或cyclin A結合成複合體的細胞週期素依賴激酶，在G1/S過渡期扮演一個關鍵的調節角色，其活性從G1期一直持續到S期。在本研究中，我們發現CDK2和cyclin A的表現量會隨著過量表現ROGDI而增加；相反地，CDK2和cyclin A的表現量會隨著降表現ROGDI而減少。進一步利用免疫沈澱法證實ROGDI與CDK2在in vivo層級具有交互作用，同時透過免疫螢光染色可觀察到ROGDI與CDK2在細胞核有共位現象。我們利用olomoucine抑制CDK2活性，結果證實過量表現ROGDI促進細胞增生是會依賴CDK2的活性。藉由流式細胞儀分析顯示降表現ROGDI會造成細胞出現G1/S期停滯的現象，此時也偵測到p53與p21蛋白表現量增加。總結以上結果，我們推論ROGDI可能是一個依賴CDK2活性的細胞週期正向調節因子。

ROGDI is a novel gene which locates on human chromosome 16p13.3 and has unknown function. The length of ROGDI coding region is 864 bp which encodes 287 amino acids. According to our previous studies, overexpression of ROGDI increased proliferation in several human cell lines. CDK2 is a member of cyclin-dependent kinases (CDKs) which plays a key role in regulation of G1/S cell cycle transition and is activated during G1 and S phases. In this studies, we found that expression of CDK2 and cyclin A were up-regulated following overexpression of ROGDI in HEK293T. On the other hand, down-regulation of CDK2 and cyclin A was observed following silencing of ROGDI. In addition, the interaction between ROGDI and CDK2 was evidenced by using immunoprecipitation. Meanwhile, we observed co-localization of ROGDI and CDK2 in the nucleus. We also exploited a drug, olomoucine, known to selectively inhibit CDK2. The result demonstrated that ROGDI-enhanced cell proliferation was dependent on CDK2 activity. Flow cytometry profiles of depletion of ROGDI displayed G1/S phase arrest as well as up-reguated the expression of p53 and p21. Taken together, we suggest that ROGDI may be a positive regulator of cell cycle and its action is CDK2-depedent.

中文摘要 1
Abstract 2
目錄 3
壹、前言 5
一、ROGDI 5
二、細胞週期 (cell cycle) 6
三、細胞週期檢查點 (cell cycle checkpoints) 9
四、細胞週期素A/細胞週期素依賴性激酶2複合體 10
五、p53-p21反應途徑 (p53-p21 pathway) 11
貳、實驗目的 12
參、材料與方法 13
一、細菌培養 13
二、細胞培養 14
三、中量質體製備 15
四、Total RNA的萃取 17
五、反轉錄作用 18
六、聚合酶連鎖反應 19
七、西方墨點法 20
八、細胞質與細胞核的分離 26
九、真核細胞轉染 27
十、利用病毒產生RNA干擾 28
十一、免疫沈澱分析 30
十二、細胞週期同步化 31
十三、細胞生長曲線 33
十四、流式細胞儀分析 33
十五、免疫螢光染色 35
十六、數據統計分析 37
肆、結果 38
伍、討論 50
陸、參考文獻 58
柒、圖表 64
捌、附錄 88

1. Ota T, Suzuki Y, Nishikawa T, et al.: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004, 36:40-45.

2. 陳桂秋: 人類基因ROGDI 蛋白質多株抗體製備及初步特性分析. 國立中山大學生物科學研究所碩士論文. 2006.

3. 莊子慧: 人類 ROGDI 蛋白之功能性分析. 國立中山大學生物科學研究所碩士論文. 2007.

4. 劉仁超: 一個調控大鼠肝星狀細胞增生、移動與活化的新基因 Rogdi 國立中山大學生物科學研究所碩士論文. 2009.

5. Norbury C, Nurse P: Animal cell cycles and their control. Annu Rev Biochem. 1992, 61:441-470.

6. Pardee AB, Dubrow R, Hamlin JL, Kletzien RF: Animal cell cycle. Annu Rev Biochem. 1978, 47:715-750.

7. Baserga R: Growth in size and cell DNA replication. Exp Cell Res. 1984, 151:1-5.

8. Baserga R: Biochemical events in the cell cycle. Natl Cancer Inst Monogr. 1969, 30:1-14.

9. Hanna DE, Rethinaswamy A, Glover CV: Casein kinase II is required for cell cycle progression during G1 and G2/M in Saccharomyces cerevisiae. J Biol Chem. 1995, 270:25905-25914.
10. Paulovich AG, Toczyski DP, Hartwell LH: When checkpoints fail. Cell. 1997, 88:315-321.

11. Resnitzky D, Hengst L, Reed SI: Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol Cell Biol. 1995, 15:4347-4352.

12. Gu Y, Turck CW, Morgan DO: Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature. 1993, 366:707-710.

13. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993, 75:805-816.

14. Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell. 1992, 71:505-514.

15. Firpo EJ, Koff A, Solomon MJ, Roberts JM: Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol. 1994, 14:4889-4901.

16. Polyak K, Kato JY, Solomon MJ, et al.: p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 1994, 8:9-22.

17. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 1994, 78:67-74.

18. Matsuoka S, Edwards MC, Bai C, et al.: p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 1995, 9:650-662.

19. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13:1501-1512.

20. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G: Cyclin A is required at two points in the human cell cycle. EMBO J. 1992, 11:961-971.
21. Preisig PA, Franch HA: Renal epithelial cell hyperplasia and hypertrophy. Semin Nephrol. 1995, 15:327-340.

22. Ohi R, Gould KL: Regulating the onset of mitosis. Curr Opin Cell Biol. 1999, 11:267-273.

23. Yang J, Kornbluth S: All aboard the cyclin train: subcellular trafficking of cyclins and their CDK partners. Trends Cell Biol. 1999, 9:207-210.

24. Rosenblatt J, Gu Y, Morgan DO: Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc Natl Acad Sci U S A. 1992, 89:2824-2828.

25. Furuno N, den Elzen N, Pines J: Human cyclin A is required for mitosis until mid prophase. J Cell Biol. 1999, 147:295-306.

26. den Elzen N, Pines J: Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase. J Cell Biol. 2001, 153:121-136.

27. Geley S, Kramer E, Gieffers C, et al.: Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J Cell Biol. 2001, 153:137-148.

28. Girard F, Strausfeld U, Fernandez A, Lamb NJ: Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell. 1991, 67:1169-1179.

29. Saha P, Chen J, Thome KC, et al.: Human CDC6/Cdc18 associates with Orc1 and cyclin-cdk and is selectively eliminated from the nucleus at the onset of S phase. Mol Cell Biol. 1998, 18:2758-2767.

30. Petersen BO, Lukas J, Sorensen CS, Bartek J, Helin K: Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J. 1999, 18:396-410.
31. Coverley D, Laman H, Laskey RA: Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nat Cell Biol. 2002, 4:523-528.

32. Jeffrey PD, Russo AA, Polyak K, et al.: Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature. 1995, 376:313-320.

33. Selvakumaran M, Lin HK, Miyashita T, et al.: Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene. 1994, 9:1791-1798.

34. Wang XW, Vermeulen W, Coursen JD, et al.: The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev. 1996, 10:1219-1232.

35. Lundberg AS, Weinberg RA: Control of the cell cycle and apoptosis. Eur J Cancer. 1999, 35:1886-1894.

36. Whitfield ML, Sherlock G, Saldanha AJ, et al.: Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell. 2002, 13:1977-2000.

37. Stuurman N, Heins S, Aebi U: Nuclear lamins: their structure, assembly, and interactions. J Struct Biol. 1998, 122:42-66.

38. Herrmann H, Foisner R: Intermediate filaments: novel assembly models and exciting new functions for nuclear lamins. Cell Mol Life Sci. 2003, 60:1607-1612.

39. Broers JL, Machiels BM, van Eys GJ, et al.: Dynamics of the nuclear lamina as monitored by GFP-tagged A-type lamins. J Cell Sci. 1999, 112 ( Pt 20):3463-3475.

40. Moir RD, Yoon M, Khuon S, Goldman RD: Nuclear lamins A and B1: different pathways of assembly during nuclear envelope formation in living cells. J Cell Biol. 2000, 151:1155-1168.

41. Vesely J, Havlicek L, Strnad M, et al.: Inhibition of cyclin-dependent kinases by purine analogues. Eur J Biochem. 1994, 224:771-786.

42. Bartek J, Lukas J: Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 2001, 490:117-122.

43. Saunders EL, Meredith MJ, Eisert DR, Freeman ML: Depletion of glutathione after gamma irradiation modifies survival. Radiat Res. 1991, 125:267-276.

44. Lamond AI, Carmo-Fonseca M: The coiled body. Trends Cell Biol. 1993, 3:198-204.

45. Ascoli CA, Maul GG: Identification of a novel nuclear domain. J Cell Biol. 1991, 112:785-795.

46. Brasch K, Ochs RL: Nuclear bodies (NBs): a newly "rediscovered" organelle. Exp Cell Res. 1992, 202:211-223.

47. Hozak P, Jackson DA, Cook PR: Replication factories and nuclear bodies: the ultrastructural characterization of replication sites during the cell cycle. J Cell Sci. 1994, 107 ( Pt 8):2191-2202.

48. Chamovitz DA, Wei N, Osterlund MT, et al.: The COP9 complex, a novel multisubunit nuclear regulator involved in light control of a plant developmental switch. Cell. 1996, 86:115-121.

49. Kato JY, Yoneda-Kato N: Mammalian COP9 signalosome. Genes Cells. 2009, 14:1209-1225.

50. von Arnim AG, Deng XW: Light inactivation of Arabidopsis photomorphogenic repressor COP1 involves a cell-specific regulation of its nucleocytoplasmic partitioning. Cell. 1994, 79:1035-1045.

51. Tomoda K, Kubota Y, Kato J: Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature. 1999, 398:160-165.

52. Oh W, Yang MR, Lee EW, et al.: Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein. J Biol Chem. 2006, 281:30166-30174.

53. Huang J, Yuan H, Lu C, et al.: Jab1 mediates protein degradation of the Rad9-Rad1-Hus1 checkpoint complex. J Mol Biol. 2007, 371:514-527.

54. Oh W, Lee EW, Sung YH, et al.: Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J Biol Chem. 2006, 281:17457-17465.

55. Porter LA, Dellinger RW, Tynan JA, et al.: Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2. J Cell Biol. 2002, 157:357-366.

56. van den Heuvel S, Harlow E: Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 1993, 262:2050-2054.

57. Resnitzky D, Reed SI: Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol Cell Biol. 1995, 15:3463-3469.

58. Sionov RV, Haupt Y: The cellular response to p53: the decision between life and death. Oncogene. 1999, 18:6145-6157.